Patents Assigned to Wellgen, Inc.
  • Bioactive compounds and methods of uses thereof
    Patent number: 7351739
    Abstract: In one aspect, the present invention provides compounds having formula I or IV as shown below: as further defined herein. In additional aspects, the present invention provides compositions and kits comprising the compounds of the invention and methods for their use, for example, for the prevention or treatment of a cancer.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: April 1, 2008
    Assignees: Wellgen, Inc., The Regents of the University of Minnesota, Rutgers, the State University of New Jersey
    Inventors: Chi-Tang Ho, Naisheng Bai, Zigang Dong, Ann M. Bode, Slavik Dushenkov
  • Benzotropolone derivatives and modulation of inflammatory response
    Patent number: 7288680
    Abstract: The present invention provides novel benzotropolone derivatives represented by the general formula: including neotheaflavate B and EGCGCa. The benzotropolone derivatives of the present invention are effective antioxidant and anti-inflammatory agents. The present invention also provides novel method of synthesizing benzotropolone compounds in high yields and method of treating inflammatory conditions using benzotropolone containing compounds.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: October 30, 2007
    Assignees: Wellgen, Inc., Rutgers, The State University of New Jersey
    Inventors: Chi-Tang Ho, Geetha Ghai, Shengmin Sang, Jin-Woo Jhoo, Mou-Tuan Huang, Robert T. Rosen, Slavik Dushenkov